Remarkably, the P-body components LSM1 and PAT1 remain highly connected to this cancer-specific network, raising the possibility that P-body disruption could have therapeutic value through selective killing of CIN cancers. This evidence concerns the gene LSM1 and cervical squamous intraepithelial neoplasia.